Team
The team comprises all collaborative investigators of the DRAGON trial. However, the following individuals are the coordinating team members based in Maastricht.
Sinéad James MD, PhD-candidate
After obtaining her M.D., Sinéad began her Ph.D. program focused on the DRAGON trials in November 2022. Any questions regarding DRAGON 1 and 2 trials, as well as the DRAGON registry, can be directed to Sinéad.
E-mail address:
sinead.james@mumc.nl
Jens Smits, BSc. PhD-candidate
Jens began his MD/PhD program focused on the DRAGON trials in 2021, combining his training as a physician with research. Any questions related to DRAGON 1 and 2 trials, as well as the DRAGON registry, may be directed to Jens.
E-mail address:
jens.smits@mumc.nl
Remon Korenblik, MD PhD-candidate
After completing his M.D. in June 2019 at Maastricht University, Remon served as a PhD-candidate for a period of three years, focusing on regenerative liver surgery at GROW (School for Oncology and Developmental Biology) Maastricht University. Presently, he is combining his surgical aspirations through his appointment in surgery at Zuyderland MC, as well as his engagement in DRAGON research.
E-mail address:
remon.korenblik@mumc.nl
Maxime Dewulf
Maxime is a surgeon specialized in Hepato-Pancreato-Biliary (HPB) surgery at the Department of Surgery in Maastricht University Medical Center+.
E-mail address:
Maxime.dewulf@mumc.nl
Christiaan van der Leij
(co-Principal Investigator)
Christiaan works at the department of Radiology in Maastricht University Medical Center+ and is the lead Interventional radiologist of the DRAGON 1 trial.
Any questions regarding the technical aspects of PVE/HVE can be directed to Christiaan.
E-mail address:
christiaan.vander.leij@mumc.nl
Ronald van Dam, MD PhD
(Principal Investigator)
Ronald is the Principal investigator of the DRAGON trials. As a surgical oncologist, in Maastricht University Medical Center+, his aim is to minimize the impact of treatment and to personalize and improve treatment options for patients with liver and pancreatic cancer.
E-mail address:
r.van.dam@mumc.nl
